Robert E Lamb

Summary

Affiliation: AstraZeneca R and D

Publications

  1. ncbi request reprint Controlling hypertension to reduce the risk of stroke
    Robert E Lamb
    Phaarm D, AstraZeneca LP, Wayne, PA 19087, USA
    Prog Cardiovasc Nurs 17:186-91. 2002
  2. ncbi request reprint Aldosterone receptor antagonists: focus on eplerenone
    Robert E Lamb
    AstraZeneca LP, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Prog Cardiovasc Nurs 18:54-9. 2003
  3. ncbi request reprint Left ventricular diastolic dysfunction: risks, identification, and treatment
    Robert E Lamb
    Medical Affairs, AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA
    Prog Cardiovasc Nurs 19:31-6. 2004
  4. ncbi request reprint Cardiovascular implications of thiazolidinedione therapy
    Robert E Lamb
    AstraZeneca LP, Wilmington, DE 19850, USA
    Prog Cardiovasc Nurs 19:116-22. 2004

Detail Information

Publications4

  1. ncbi request reprint Controlling hypertension to reduce the risk of stroke
    Robert E Lamb
    Phaarm D, AstraZeneca LP, Wayne, PA 19087, USA
    Prog Cardiovasc Nurs 17:186-91. 2002
    ..This review briefly summarizes the significance of controlling hypertension to reduce the risk of stroke by reviewing some of the clinical trials that support pharmacologic intervention...
  2. ncbi request reprint Aldosterone receptor antagonists: focus on eplerenone
    Robert E Lamb
    AstraZeneca LP, 725 Chesterbrook Boulevard, Wayne, PA 19087, USA
    Prog Cardiovasc Nurs 18:54-9. 2003
    ..The objective of this review is to summarize the renin-angiotensin-aldosterone system, emphasizing the role for aldosterone antagonism in the management of hypertension, with a focus on eplerenone...
  3. ncbi request reprint Left ventricular diastolic dysfunction: risks, identification, and treatment
    Robert E Lamb
    Medical Affairs, AstraZeneca LP, 1800 Concord Pike, Wilmington, DE 19850, USA
    Prog Cardiovasc Nurs 19:31-6. 2004
    ....
  4. ncbi request reprint Cardiovascular implications of thiazolidinedione therapy
    Robert E Lamb
    AstraZeneca LP, Wilmington, DE 19850, USA
    Prog Cardiovasc Nurs 19:116-22. 2004
    ....